Neuphoria Therapeutics Net Profit Margin Growth & History (NEUP)
Neuphoria Therapeutics's net profit margin was −2.36% for fiscal 2025.
View full Neuphoria Therapeutics company overviewNeuphoria Therapeutics annual net profit margin history
| Fiscal year | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-06-30 | −2.36% | — |
| 2022 | 2022-06-30 | −8,253.62% | — |
Neuphoria Therapeutics quarterly net profit margin
| Fiscal quarter | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| Q3 2025 | 2025-03-31 | 75.08% | — |
| Q2 2025 | 2024-12-31 | −293.24% | — |
Neuphoria Therapeutics net profit margin trends
Between the periods ended 2022-06-30 and 2025-06-30, Neuphoria Therapeutics's net profit margin increased from −8,253.62% to −2.36%, a change of +8251.26 percentage points. The latest reported quarter, Q3 2025, shows 75.08%.
What net profit margin means
Net profit margin measures the percentage of revenue remaining as net income after operating costs, interest, taxes, and other expenses. It shows how much bottom-line profit or loss a company generates from each dollar of revenue.
How net profit margin is calculated
TickerStat calculates net profit margin as SEC-reported net income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Neuphoria Therapeutics source filings ↗